Prevention

Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women

Retrieved on: 
Tuesday, March 14, 2023
SAN, Pharmacy, Patient, Korea Disease Control and Prevention Agency, Food, Visby, STI, Associate, Neisseria gonorrhoeae, PCR, Gonorrhea, Trichomonas vaginalis, Risk, Prevention, Polymerase chain reaction, Woman, Workflow, Education, Health, Chlamydia trachomatis, MD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Diagnosis, CLIA, POC, Stanford University, Pelvic inflammatory disease, Pharmaceutical industry, Birth control, Operation, Medicine, Neisseria, Trichomonas, Chlamydia

The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.

Key Points: 
  • The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.
  • The CLIA-waived, Sexual Health POC test provides accurate results in under 30 minutes, enabling clinicians to test, talk and accurately treat with confidence in a single patient visit.
  • "The Visby Sexual Health Test has been a game changer for us.
  • The Visby test is a win-win, helping fight antibiotic resistance as well as the spread of untreated infection, while empowering patients to engage health services with greater confidence."

Mpox a Cause for Concern in Pregnant Persons

Retrieved on: 
Wednesday, March 1, 2023
Women, Other Health, Other Science, Parenting, Men, Research, Baby, Maternity, Infectious Diseases, Consumer, Science, Clinical Trials, Managed Care, General Health, Biotechnology, Health, Health Technology, Primary, Secondary, Health Insurance, Education, Infection, Smallpox, Cytomegalovirus, Skin, Viral, CAP, Stillbirth, Disease, Pathology, Pregnancy, College, Monkeypox virus, Mpox, Prevention, Liver, Fluid mechanics, Medical laboratory, Fetus, Woman, Archive, Archives of Pathology & Laboratory Medicine, COVID-19, Placenta, Health care, Vaccine, Birth control, MD

Mpox was known to infect pregnant persons in Africa, producing a 75 percent perinatal fatality rate.

Key Points: 
  • Mpox was known to infect pregnant persons in Africa, producing a 75 percent perinatal fatality rate.
  • They provide insight about how mpox can infect the fetus and describe details of a stillborn with placental infection, define and illustrate the Congenital Mpox Syndrome, and discuss mechanisms of intrauterine mpox transmission.
  • Although most mpox infections occurred in men, cases in women have increased, resulting in an intense concern for pregnant individuals acquiring the infection.
  • Healthcare providers should be aware that mpox occurring in pregnant persons is uncommon but has the capability to infect the fetus as well as the newborn and cause both perinatal morbidity and mortality.”

Caraway and Ash Wellness Partner to Address Surge in Gen Z Sexually Transmitted Infections

Retrieved on: 
Tuesday, February 14, 2023
STI, Pediatrics, Google Play, American Academy of Pediatrics, Korea Disease Control and Prevention Agency, Chlamydia, Bangladesh Technical Education Board, Hepatitis C, Trichomoniasis, Gen, Candidiasis, Bacterial vaginosis, Generation Z, HIV, Student, American Academy, Syphilis, Urine, Partnership, Multimedia, Gonorrhea, Prevention, App Store (iOS/iPadOS), Infection, Nursing, Birth control, Caraway

NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Caraway, a digital healthcare company for Gen Z, announces its partnership with Ash Wellness, an at-home diagnostics and testing company, to combat the rise in sexually transmitted infections (STIs) on college campuses. Caraway's members can now access complimentary, discrete and on-demand STI kits delivered directly to their addresses in New York, California, Ohio and North Carolina, with follow-up guidance and treatment by an integrated care team.  The partnership provides Gen Z with the tools they need to prioritize their sexual health on their own terms.

Key Points: 
  • The partnership provides Gen Z with the tools they need to prioritize their sexual health on their own terms.
  • "In collaboration with Ash Wellness, we selected the most relevant panel of tests for Gen Z instantly accessible via our mobile app, with the wraparound guidance and treatment from our care team.
  • "Gen Z doesn't get tested for a variety of reasons, but some of the most prevalent we've seen are convenience, cost and stigma.
  • Gen Z, ages 18-2, sign up for a Caraway membership via its mobile app in the Apple App Store and on Google Play .

PCPD Publishes Investigation Report on Security Measures Taken by 14 Restaurants to Protect Customers’ Registration Data

Retrieved on: 
Friday, November 11, 2022
Book, American Seafoods, Sheung Shui, Business, Privacy Commissioner, House, Nathan Road, Investigation, Requirement, National Minimum Wage (Enforcement Notices) Act 2003, LeaveHomeSafe, Queensway, Person, Collection, Complaint, Privacy, Prevention, Workflow, Independence Building, Restaurant, DPP, Awareness, Government, Name, Personal data, Annex, Fortune City One, Recurrence, Presentence investigation report, Tung Lo Wan Road, COVID-19, Control, Regardless, Compliance, Internet service provider, Satellite navigation device, Fast food, Bridge, Dry cleaning, Hospitality industry, Diesel fuel, Palladium, Propane, Causeway Bay, Portland Street, Admiralty

Date: 28 October 2021

Key Points: 


Date: 28 October 2021

UAE Government Organisations Partner with CanaGulf for ISO Standard & Global Award Implementation

Retrieved on: 
Wednesday, October 26, 2022
Ministry, Certification, Moe, Prevention, City, Government, Green, Gender equality, Artificial intelligence, QHSE, CSE, Ministry of Energy, SEWA, EHS, Industry, Global Certification Commission, DEWA, Dubai Police Force, Electricity, Certificate, ISO, Health policy, DQS, Accreditation, GC, Medical device, Health, Environment, Holcim

Dubai, United Arab Emirates--(Newsfile Corp. - October 26, 2022) - CanaGulf International Standardisation, a consulting, auditing, and training corporation, based in the UAE, partners with multiple UAE government organisations for the successful implementation of Global award and International Standard Organisation (ISO) management systems.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - October 26, 2022) - CanaGulf International Standardisation, a consulting, auditing, and training corporation, based in the UAE, partners with multiple UAE government organisations for the successful implementation of Global award and International Standard Organisation (ISO) management systems.
  • Established in 2016, CanaGulf International Standardisation concentrates on giving businesses the resources and expertise they need to succeed in their respective fields.
  • In 2021, CanaGulf supported MOHAP (Ministry of Health and Prevention - UAE) to receive the global Certificate GC mark in health crisis management and health policy management.
  • EHS was the first to receive the ISO certification in Health Governance worldwide due to quality implementation services of CanaGulf.

IBSA Group and Granata Bio announces first patient screened in pivotal PROGRESS clinical trial of Progesterone-IBSA

Retrieved on: 
Wednesday, October 19, 2022
Reproductive health, Disease, Centers for Disease Control and Prevention timeline, Woman, Vaginal bleeding, Blastocyst, Luteal phase, Progesterone, Patient, ART, Malignancy, Multimedia, IBSA, Transfer, Rest, Plasma protein binding, III, Marketing, Health, CEO, PROGRESS, Breast, Ageing, Safety, Clinical trial, Infertility, Liver, Center, Pregnancy, Thrombophlebitis, Apoplexy, Prevention, Pharmaceutical industry, Birth control

BOSTON, Oct. 20, 2022 /PRNewswire/ -- IBSA Group and Granata Bio today announced the screening of the first patient in the pivotal phase III PROGRESS (PROGesterone fRozenEuploid blaStocyst tranSfer) clinical trial (Clinical Trials.gov Identifier: NCT04549116).

Key Points: 
  • BOSTON, Oct. 20, 2022 /PRNewswire/ -- IBSA Group and Granata Bio today announced the screening of the first patient in the pivotal phase III PROGRESS (PROGesterone fRozenEuploid blaStocyst tranSfer) clinical trial (Clinical Trials.gov Identifier: NCT04549116).
  • The study is expected to enroll about 680 patients between the ages of 35-42 years old.
  • "The IBSA Group is excited for this key milestone in development of our subcutaneous progesterone in the United States.
  • IBSA Group, headquartered in Lugano, Switzerland, is a leader in reproductive health and has a diversified product portfolio of prescription drugs and biologics.

InvestmentPitch Media Video Discusses LOVE Pharma’s Shareholders’ Letter from CEO Zach Stadnyk

Retrieved on: 
Friday, August 26, 2022
Inflammation, Partnership, National Institute on Drug Abuse, CEO, CSE, OTC, Female, Pain, Research, Centers for Disease Control and Prevention, Time-invariant system, Awareness, First Nations in Ontario, Autumn, Sale, United Nations, Cognitive behavioral therapy, Tongue, Anxiety, Johns Hopkins, FSE, Science, Hygiene, World Health Organization, Prevention, American College, Johns Hopkins University, Patent, LOVE, Research report, DOC, GLOBE, Social Problems, Center, FDA, Company, Biotechnology, Lubrication, Suggestion, News, B2B, World, Risk, Growth, Health, CDC, Patient, Pharmaceutical industry, Drug, CBD, B2C, Love

Zach Stadnyk, CEO, stated: We welcome this opportunity to provide our shareholders with a comprehensive picture of Love's efforts in building upon its existing portfolio and establishing its future strategic imperatives.

Key Points: 
  • Zach Stadnyk, CEO, stated: We welcome this opportunity to provide our shareholders with a comprehensive picture of Love's efforts in building upon its existing portfolio and establishing its future strategic imperatives.
  • A Media Snippet accompanying this announcement is available by clicking on the image or link below:
    For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company.
  • If these links are not enabled, please visit www.InvestmentPitch.com and enter Love Pharma in the search box.
  • For more information, please visit the companys website www.love-pharma.com, contact Zach Stadnyk, CEO, at 604-343-2977 or by email at [email protected].

Cybereason Named to the Prestigious Forbes 2022 Cloud 100

Retrieved on: 
Tuesday, August 9, 2022
Cloud, Salesforce, Defender, Bessemer Venture Partners, CEO, AI, Cybereason, EMEA, Kraft Heinz, Forbes, GE Healthcare, Research, History, CISO-FM, Company, XDR, TikTok, CNBC, Partnership, APAC, MITRE, Commercial software, Rebecca Malope, Prevention, Colgate-Palmolive, Enterprise, Food delivery, Weapon, Management, Visibility

--Being named to CNBC's 10th Annual Disruptor 50 list of the most innovative privately held global companies. This was the second consecutive year Cybereason was named a Disruptor. More than 1600 nominations were accepted.

Key Points: 
  • Cybereason joins other top private companies on this year's Forbes Cloud 100 list.
  • BOSTON, Aug. 9, 2022 /PRNewswire-PRWeb/ -- Cybereason , the XDR company, today announced it has been named to the exclusive Forbes 2022 Cloud 100 , the definitive ranking of the top 100 private cloud companies in the world, published by Forbes in partnership with Bessemer Venture Partners and Salesforce Ventures .
  • "Joining other top private companies on the Forbes 2022 Cloud 100 further validates what sets Cybereason apart from our competitors, empowering Defenders to understand in real-time.
  • For the seventh straight year, the Cloud 100 reviews submissions from hundreds of cloud startups and private companies each year.

Mindpath Health Announces Launch of Mindpath College Health

Retrieved on: 
Tuesday, August 2, 2022
Acquisition, Psychotherapy, Psychiatry, Wellness, Physician, TMS, Student, VP, Transcranial magnetic stimulation, University, Multimedia, Pressure, Prevention, Suicide, Patient, Depression, Faculty, Health, American Public Media, Korea Disease Control and Prevention Agency, Animal, Center, United States Public Health Service, Anxiety, Medicine

DENVER, Aug. 2, 2022 /PRNewswire/ -- Mindpath Health, a leading independent U.S. provider of high quality, outpatient behavioral health services, today announced the rebrand of Acacia Counseling and Wellness to Mindpath College Health, alongside a new dedicated website, College.Mindpath.com. The announcement comes on the heels of Mindpath Health's May 2022 acquisition of Acacia Counseling and Wellness, a top provider of accessible psychiatry, telehealth, and specialized long-term psychotherapy for university students and their communities. Mindpath College Health is designed to radically improve college student access to mental health care services in the U.S., and will continue to expand into other states, providing additional mental health resources for university systems.

Key Points: 
  • Recently acquired Acacia Counseling and Wellness rebrand to Mindpath College Health highlights Mindpath Health's commitment to help meet the surging demand for mental health services across U.S. university campuses and communities
    DENVER, Aug. 2, 2022 /PRNewswire/ -- Mindpath Health , a leading independent U.S. provider of high quality, outpatient behavioral health services, today announced the rebrand of Acacia Counseling and Wellness to Mindpath College Health, alongside a new dedicated website, College.Mindpath.com .
  • "Our recent acquisition of Acacia Counseling and Wellness - now Mindpath College Health - is already increasing access to quality mental health care for many college communities in California and Minnesota," said Mindpath Health CEO, Christopher Brengard.
  • "Utilizing Mindpath Health resources, platforms and championed payor relationships, Mindpath College Health will continue to increase much needed access to care.
  • "We worked collaboratively with Mindpath Health post-acquisition to create Mindpath College Health, which perfectly reflects our expanded mission of offering tailored, collaborative and accessible care to university communities nationwide," said Dr. Brett Donnelly, VP of Development, Mindpath College Health.

The Center for Active Design & QuadReal Release New Benchmarking Report Showing Prioritization of Health Strategies in Buildings Associated with Increased Tenant Satisfaction Outcomes & Real Estate Portfolio Value

Retrieved on: 
Wednesday, June 8, 2022
Built environment, General Services Administration, Goal, Friends, Program, Research, Ownership, CEO, EHS, CFAD-FM, Prevention, Record, Senior, CDC, Center, NPS, Investment, Multimedia, Net, Tenant, Real estate, Health, NEW, Industry, Benchmarking, Sustainability, Insurance, Risk management, Management, Fitwell

NEW YORK, June 8, 2022 /PRNewswire/ -- The Center for Active Design (CfAD), preeminent global organization working at the intersection of health and the built environment and the sole licensed operator of Fitwel®, the healthy building certification system, and QuadReal Property Group (QuadReal), a global real estate investment, operating and development company, today announced the release of "Health Drives Value in Real Estate," a new report that records the positive outcomes that health and wellbeing strategies have on tenant satisfaction, and in turn, financial outcomes. This report takes a people-focused (health) approach to looking at a portfolio of buildings, and found that evidence-based, health-promoting strategies can foster tenant satisfaction.

Key Points: 
  • This report takes a people-focused (health) approach to looking at a portfolio of buildings, and found that evidence-based, health-promoting strategies can foster tenant satisfaction.
  • "This research makes clear the value of benchmarking to transform the information about a portfolio into a pathway that owners and investors can act on to plan future investments.
  • "One of the QuadReal team's sustainability goals is to provide healthy buildings to our tenants and residents so they can flourish.
  • QuadReal Property Group is a global real estate investment, operating and development company headquartered in Vancouver, British Columbia.